Financhill
Buy
60

PTGX Quote, Financials, Valuation and Earnings

Last price:
$93.51
Seasonality move :
37.92%
Day range:
$91.07 - $93.07
52-week range:
$33.70 - $93.25
Dividend yield:
0%
P/E ratio:
145.67x
P/S ratio:
28.29x
P/B ratio:
8.94x
Volume:
800.8K
Avg. volume:
957.7K
1-year change:
125%
Market cap:
$5.8B
Revenue:
$434.4M
EPS (TTM):
$0.63

PTGX Analysts' Consensus Rating

The 9 analysts providing 12-month price projections for Protagonist Therapeutics, Inc. shares anticipate an average target of $92.83, ranging from a low estimate of $65.00 to a high estimate of $115.00. This average target implies a growth of 0.63% compared to the current stock price of $92.25.

Consensus Price Target

$92.83

Highest Price Target

$115.00

Lowest Price Target

$65.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 6 9 8

Hold 1 1 1

Sell 0 0 0
Consensus Buy Buy Buy

PTGX Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is JetBlue The Best Airline Stock?
Is JetBlue The Best Airline Stock?

Following a general trend of improvement among airline stocks, shares…

Why Did Netflix Buy Warner Bros?
Why Did Netflix Buy Warner Bros?

Following a bidding war, Netflix (NASDAQ:NFLX) has announced its intention…

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Stock Ideas

Buy
51
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy
58
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
59
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
54
SMX alert for Dec 12

SMX (Security Matters) Plc [SMX] is down 7.54% over the past day.

Buy
77
DHIL alert for Dec 12

Diamond Hill Investment Group, Inc. [DHIL] is up 0.06% over the past day.

Sell
28
OXM alert for Dec 12

Oxford Industries, Inc. [OXM] is up 9.98% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock